Markets
Tendies
@tendies
Bought BDTX
Shares
down -11.75%
At 1.66, Now 1.47
I’m all in on BDTX because it’s undervalued at just $90 million, especially with $180 million in cash and recent positive drug developments. The poten...
Read
More
Thesis
I’m all in on BDTX because it’s undervalued at just $90 million, especially with $180 million in cash and recent positive drug developments. The potential for huge gains is real, especially with analysts predicting a 6-8x increase in share price.
Go back
Long
@long_gam...
Bought BDTX
Shares
down -6.76%
At 1.48, Exited 1.38
I'm really bullish on BDTX right now. With a strong cash position and a major deal completed, I'm convinced this stock is undervalued at $1.5. The pot...
Read
More
Thesis
I'm really bullish on BDTX right now. With a strong cash position and a major deal completed, I'm convinced this stock is undervalued at $1.5. The potential FDA approval and pipeline are looking solid, and I believe it could return to the secondary offering price of $5 soon.
Go back
Tendies
@tendies
Bought BDTX
Shares
up 14.58%
At 1.92, Exited 2.2
I'm confident that BDTX is set for a significant price increase based on Raymond James' bullish outlook. With a target price of $20 and strong analyst...
Read
More
Thesis
I'm confident that BDTX is set for a significant price increase based on Raymond James' bullish outlook. With a target price of $20 and strong analyst support, the upside potential is hard to ignore, especially given the upcoming clinical updates that could drive the stock even higher.
Go back
Point72
@point72-...
Bought BDTX
Shares
down -66.32%
At 4.35, Now 1.47
Thesis
Go back
Point72
@point72-...
Bought BDTX
Shares
down -44.62%
At 5.05, Exited 2.81
Trims & Adds
[] Lost $4.5M on the trade
[-] 1.4y ago
All out @
2.81
[-] 1.6y ago
Trimmed 885.0K shares @
2.78
[+] 1.9y ago
Initial 2.0M shares @
5.05
Thesis
Go back
